OK2BX Foundation – Trademark Portfolio

Entity Type: 54

OK2BX Foundation holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 2 filings in this category. The portfolio also extends into Class 14 (Jewelry) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include OK2BX and OK2BX*FILM. The owner is based in Dallas, TX.

1717 One Arts Plaza, Suite 1802

Dallas, TX 75208

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

OK2BX
OK2BX
Registered 2022
OK2BX
OK2BX
Registered 2022

Trademark Classifications

OK2BX Foundation's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

41
Education & Entertainment (2 filings)

Education; providing of training; entertainment; sporting and cultural activities

14
Jewelry (1 filing)

Precious metals and their alloys; jewellery, precious stones; horological instruments

Frequently Asked Questions

How many trademarks does OK2BX Foundation have?

OK2BX Foundation has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does OK2BX Foundation file in?

OK2BX Foundation files trademarks across 2 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 14 (Jewelry). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.

What are OK2BX Foundation's most well-known trademarks?

OK2BX Foundation's registered trademark portfolio includes well-known marks such as OK2BX and OK2BX*FILM. These are among 3 currently registered trademarks in the portfolio.

What is OK2BX Foundation's trademark registration success rate?

OK2BX Foundation has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.